Telomerase activity determined by conventional telomeric repeat amplification protocol and reverse transcriptase‐polymerase chain reaction assay in ovarian lesions: A comparison of assays

References

• Danish Cancer Association (accessed January 2005). Webpage 2000. Ref type: Internet communication
   Google Scholar
• Kutteh W. H., Miller D. S., Mathis J. M. Immunologic characterization of tumour markers in human ovarian cancer cell lines. J Soc Gynecol Invest 1996; 3: 216–22
   PubMedGoogle Scholar
• MacDonald N. D., Rosenthal A. N., Jacobs I. J. Screening for ovarian cancer. Ann Acad Med Singapore 1998; 27: 676–82
   PubMedGoogle Scholar
• Rustin G. J. Can we now agree to use the same definition to measure response according to CA‐125?. J Clin Oncol 2004; 22: 4035–6
   PubMed Web of Science ®Google Scholar
• Tung X. W., Kieback G. D., Ramesh R., Freeman S. M. Molecular aspects of ovarian cancer. Curr Ther Issues Gynaecol Cancer 1999; 13: 109–33
   Google Scholar
• Kammerer‐Doak D. N., Magrina J. F., Nemiro J. S., Lidner T. K. Benign gynecologic conditions associated with a CA‐125 level >1,000 U/mL. A case report. J Reprod Med 1996; 41: 179–82
   PubMed Web of Science ®Google Scholar
• Crayford T. J., Campbell S., Bourne T. H., Rawson H. J., Collins W. P. Benign ovarian cysts and ovarian cancer: a cohort study with implications for screening. Lancet 2000; 355: 1060–3
   PubMed Web of Science ®Google Scholar
• de Kok J. B., Ruers T. J., van Muijen G. N., van Bokhoven A., Willems H. L., Swinkels D. W. Real‐time quantification of human telomerase reverse transcriptase mRNA in tumors and healthy tissues. Clin Chem 2000; 46: 313–8
   PubMed Web of Science ®Google Scholar
• Kyo S., Takakura M., Tanaka M., Kanaya T., Inoue M. Telomerase activity in cervical cancer is quantitatively distinct from that in its precursor lesions. Int J Cancer 1998; 79: 66–70
   PubMed Web of Science ®Google Scholar
• Meeker A. K., Coffey D. S. Telomerase: a promising marker of biological immortality of germ, stem, and cancer cells [review]. Biochemistry (Mosc ) 1997; 62: 1323–31
   PubMed Web of Science ®Google Scholar
• Urquidi V., Tarin D., Goodison S. Telomerase in cancer: clinical applications. Annu Med 1998; 30: 419–30
   PubMed Web of Science ®Google Scholar
• Yajima T., Yagihashi A., Kameshima H., Kobayashi D., Furuya D., Hirata K., et al. Quantitative reverse transcription‐PCR assay of the RNA component of human telomerase using the TaqMan fluorogenic detection system. Clin Chem 1998; 44: 2441–5
   PubMed Web of Science ®Google Scholar
• Sharma H. W., Maltese J. Y., Zhu X., Kaiser H. E., Narayanan R. Telomeres, telomerase and cancer: is the magic bullet real?. Anticancer Res 1996; 16: 511–5
   PubMed Web of Science ®Google Scholar
• Duncan E. L., Reddel R. R. Genetic changes associated with immortalization [review]. Biochemistry (Mosc) 1997; 62: 1263–74
   PubMed Web of Science ®Google Scholar
• Kim N. W., Piatyszek M. A., Prowse K. R., Harley C. B., West M. D., Ho P. L., et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011–5
   PubMed Web of Science ®Google Scholar
• Cech T. R., Nakamura T. M., Lingner J. Telomerase is a true reverse transcriptase [review]. Biochemistry (Mosc) 1997; 62: 1202–5
   PubMed Web of Science ®Google Scholar
• Lo Y. M. Quantitative assays for telomerase: means for studying the end. Clin Chem 1998; 44: 2399–400
   PubMed Web of Science ®Google Scholar
• Greider C. W., Blackburn E. H. Telomeres, telomerase and cancer. Sci Am 1996; 274: 92–7
   PubMed Web of Science ®Google Scholar
• Dokudovskaya S. S., Petrov A. V., Dontsova O. A., Bogdanov A. A. Telomerase is an unusual RNA‐containing enzyme [review]. Biochemistry (Mosc) 1997; 62: 1206–15
   PubMed Web of Science ®Google Scholar
• Ishikawa F. Regulation mechanisms of mammalian telomerase [review]. Biochemistry (Mosc) 1997; 62: 1332–7
   PubMed Web of Science ®Google Scholar
• Kyo S., Kanaya T., Takakura M., Tanaka M., Yamashita A., Inoue H., et al. Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors. Int J Cancer 1999; 80: 804–9
   PubMed Web of Science ®Google Scholar
• Krupp G., Kuhne K., Tamm S., Klapper W., Heidorn K., Rott A., et al. Molecular basis of artifacts in the detection of telomerase activity and a modified primer for a more robust “TRAP” assay. Nucleic Acids Res 1997; 25: 919–21
   PubMed Web of Science ®Google Scholar
• Sellner L. N., Lock P. M., Turbett G. R. Simplified method for the telomeric repeat amplification protocol (TRAP). Biotechniques 1998; 24: 726–8
   PubMed Web of Science ®Google Scholar
• Uehara H., Nardone G., Nazarenko I., Hohman R. J. Detection of telomerase activity utilizing energy transfer primers: comparison with gel‐ and ELISA‐based detection. Biotechniques 1999; 26: 552–8
   PubMed Web of Science ®Google Scholar
• Wright W. E., Shay J. W., Piatyszek M. A. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995; 23: 3794–5
   PubMed Web of Science ®Google Scholar
• Lehner R., Enomoto T., McGregor J. A., Shroyer A. L., Haugen B. R., Pugazhenthi U., et al. Quantitative analysis of telomerase hTERT mRNA and telomerase activity in endometrioid adenocarcinoma and in normal endometrium. Gynecol Oncol 2002; 84: 120–5
   PubMed Web of Science ®Google Scholar
• Hou M., Xu D., Bjorkholm M., Gruber A. Real‐time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity. Clin Chem 2001; 47: 519–24
   PubMed Web of Science ®Google Scholar
• Krarup H. B., Drewes A. M., Madsen P. H. A quantitative HCV‐PCR test for routine diagnostics. Scand J Clin Lab Invest 1998; 58: 415–22
   PubMed Web of Science ®Google Scholar
• Widschwendter A., Muller H. M., Hubalek M. M., Wiedemair A., Fiegl H., Goebel G., et al. Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer. Gynecol Oncol 2004; 93: 407–16
   PubMed Web of Science ®Google Scholar
• Gauthier L. R., Granotier C., Soria J. C., Faivre S., Boige V., Raymond E., et al. Detection of circulating carcinoma cells by telomerase activity. Br J Cancer 2001; 84: 631–5
   PubMed Web of Science ®Google Scholar
• Sapi E., Okpokwasili N. I., Rutherford T. Detection of telomerase‐positive circulating epithelial cells in ovarian cancer patients. Cancer Detect Prev 2002; 26: 158–67
   PubMedGoogle Scholar
• Lledo S. M., Garcia‐Granero E., Dasi F., Ripoli R., Garcia S. A., Cervantes A., et al. Real time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA in patients with colorectal cancer. Colorectal Dis 2004; 6: 236–42
   PubMedGoogle Scholar
• Li C. P., Huang T. S., Chao Y., Chang F. Y., Whang‐Peng J., Lee S. D. Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies. World J Gastroenterol 2004; 10: 2468–71
   PubMed Web of Science ®Google Scholar